PUMA BIOTECHNOLOGY, INC. Other Noncash Income (Expense)
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Other Noncash Income (Expense) of -$179.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2015-08-10
- PUMA BIOTECHNOLOGY, INC. other noncash income (expense) for the quarter ending 2015-06-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. other noncash income (expense) for the quarter ending 2015-03-31 was -$179.00K.
- PUMA BIOTECHNOLOGY, INC. other noncash income (expense) for the quarter ending 2014-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. other noncash income (expense) for the quarter ending 2014-03-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. other noncash income (expense) for fiscal 2014 was -$192.00K.
- PUMA BIOTECHNOLOGY, INC. other noncash income (expense) for fiscal 2012 was -$464.00K.
- PUMA BIOTECHNOLOGY, INC. other noncash income (expense) for fiscal 2011 was -$439.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed | Other Noncash Income (Expense) 16 month | Other Noncash Income (Expense) 18 month | Other Noncash Income (Expense) 21 month | Other Noncash Income (Expense) 25 month | Other Noncash Income (Expense) 27 month | Other Noncash Income (Expense) 30 month | Other Noncash Income (Expense) 33 month | Other Noncash Income (Expense) 36 month | Other Noncash Income (Expense) 39 month | Other Noncash Income (Expense) 42 month | Other Noncash Income (Expense) 45 month | Other Noncash Income (Expense) 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$179.00K 10-Q · filed 2015-08-10 | ||||||||||||||||||
| 2015-03-31 | -$179.00K 10-Q · filed 2015-05-11 | |||||||||||||||||||
| 2014-12-31 | -$192.00K 10-K · filed 2015-03-02 | |||||||||||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 48 month − 10-Q 45 month · filed 2014-11-10 | -$903.00K 10-Q · filed 2014-11-10 | ||||||||||||||||||
| 2014-06-30 | -$903.00K 10-Q · filed 2014-08-11 | |||||||||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 42 month − 10-K 39 month · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2014-05-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-12 | $0.00 derived: sum of 4 quarters · filed 2014-05-12 | -$903.00K 10-Q · filed 2014-05-12 | |||||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 39 month − 10-Q 36 month · filed 2014-03-03 | $0.00 derived: sum of 2 quarters · filed 2014-03-03 | $0.00 derived: sum of 3 quarters · filed 2014-03-03 | $0.00 derived: sum of 4 quarters · filed 2014-03-03 | -$903.00K 10-K · filed 2014-03-03 | |||||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 36 month − 10-Q 33 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 derived: sum of 3 quarters · filed 2013-11-12 | -$227.00K derived: sum of 4 quarters · filed 2015-03-02 | -$903.00K 10-Q · filed 2013-11-12 | |||||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 33 month − 10-Q 30 month · filed 2013-08-06 | $0.00 derived: sum of 2 quarters · filed 2013-08-06 | -$227.00K derived: sum of 3 quarters · filed 2015-03-02 | -$227.00K derived: sum of 4 quarters · filed 2015-03-02 | -$903.00K 10-Q · filed 2013-08-06 | |||||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 30 month − 10-K 27 month · filed 2013-05-09 | -$227.00K derived: sum of 2 quarters · filed 2015-03-02 | -$227.00K derived: sum of 3 quarters · filed 2015-03-02 | -$228.00K derived: sum of 4 quarters · filed 2015-03-02 | -$903.00K 10-Q · filed 2013-05-09 | |||||||||||||||
| 2012-12-31 | -$227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$227.00K derived: sum of 2 quarters · filed 2015-03-02 | -$228.00K derived: sum of 3 quarters · filed 2015-03-02 | -$464.00K 10-K · filed 2015-03-02 | -$903.00K 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$1.00K derived: sum of 2 quarters · filed 2013-11-12 | -$237.00K 10-Q · filed 2013-11-12 | -$236.53K 10-Q · filed 2012-11-14 | -$675.95K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$237.00K 10-Q · filed 2013-08-06 | -$236.53K 10-Q · filed 2012-08-14 | -$675.95K 10-Q · filed 2012-08-14 | ||||||||||||||||
| 2012-03-31 | -$236.00K 10-Q · filed 2013-05-09 | -$236.53K 10-Q · filed 2012-05-15 | -$675.95K 10-Q · filed 2012-05-15 | |||||||||||||||||
| 2011-12-31 | -$439.00K 10-K · filed 2014-03-03 | -$439.42K 10-K · filed 2012-03-29 | -$439.42K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |